The study is to assess the retinal biomarkers in patients diagnosed with macular telangiectasia.

Multimodal Imaging Biomarkers in monitoring the progression of Macular Telangiectasia.

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/03/012742

Enrollment

Registered

2018-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed with macular telangiectasia.

Exclusion criteria

Exclusion criteria: Other macular diseases

Design outcomes

Primary

Measure	Time frame
Progression of the disease is assessed using multimodal imaging methods.Timepoint: 18 months period	—

Secondary

Measure	Time frame
Comparison of different investigative modalitiesTimepoint: 18 Months period	—

Countries

India

Contacts

Public ContactDr Jay Sheth

Giridhar Eye Institute

girieye@vsnl.com9995530115

Outcome results